Markov chain Monte Carlo estimation of a multiparameter decision model: Consistency of evidence and the accurate assessment of uncertainty

Medical Decision Making

Volumn 22, Issue 4, 2002, Pages 359-371

  Ades, A E ^a   Cliffe, S ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bayesian methods; Decision analysis; Epidemiology; Evidence synthesis; Expected value of perfect information; HIV; Incremental net benefit; Markov chain Monte Carlo; Screening

Indexed keywords

ARTICLE; BAYES THEOREM; COMPUTER PROGRAM; EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; HIGH RISK POPULATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL DECISION MAKING; MONTE CARLO METHOD; PROBABILITY;

ADULT; AIDS SERODIAGNOSIS; BAYES THEOREM; COMPUTER SIMULATION; DECISION SUPPORT SYSTEMS, CLINICAL; EVIDENCE-BASED MEDICINE; FEMALE; HIV INFECTIONS; HUMANS; MARKOV CHAINS; MATHEMATICAL COMPUTING; MONTE CARLO METHOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SOFTWARE;

EID: 0036076656     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/027298902400448920     Document Type: Article

References (57)

1. Primer on medical decision analysis: Part 3 - Estimating probabilities and utilities
2. Probabilistic sensitivity analysis using Monte Carlo simulation: A practical approach
3. Probabilistic analysis of decision trees using Monte Carlo simulation
4. Monte Carlo techniques for quantitative uncertainty analysis in public health risk assessments
5. Reflecting uncertainty in decision analysis
6. An introduction to a Bayesian method for meta-analysis: The confidence profile method
7. A Bayesian method for synthesising evidence: The confidence profile method
8. The confidence profile method: A Bayesian method for assessing health technologies
9. An influence diagram approach to medical technology assessment
10. Cost effectiveness analysis of antenatal HIV screening in United Kingdom
11. Selective versus universal antenatal HIV testing: Epidemiological and implementational factors in policy choice
12. A cost-effectiveness analysis of antenatal HIV testing in the UK
13. Economic issues in the prevention of vertical transmission of HIV
14. Effect of the worldwide epidemic on HIV prevalence in the United Kingdom: Record linkage in anonymous neonatal seroprevalence surveys
15. Vertically transmitted HIV infection in the British Isles
16. Epidemiology and detection of HIV-1 among pregnant women in the United Kingdom: Results from national surveillance 1988-96
17. Use of anonymous new-born serosurveys to evaluate antenatal HIV screening programmes
18. The emerging genetic diversity of HIV: The importance of global surveillance for diagnostics, research, and prevention
19. Serotype, parental country of birth, and ethnic status in unlinked anonymous neonatal HIV seroprevalence surveys
20. Antenatal and neonatal haemoglobinopathy screening in the UK: Review and economic analysis
21. An economic approach to clinical trial design and research priority-setting
22. Net health benefits: A new framework for the analysis of uncertainty in cost-effectiveness analyses
23. Sampling-based approaches to calculating marginal densities
24. Spatial interaction and the statistical analysis of lattice systems
25. Evaluating the accuracy of sampling based approaches to the calculation of posterior moments
26. Bayesian measures of model complexity and fit
27. Sensitivity Analysis and the Expected Value of Perfect Information
28. Going beyond the single number: Using probabilistic risk assessment to improve risk management
29. The value of improved national exposure information for perchloroethylene (Perc): A case study for dry cleaners
30. The irrelevance of inference: A decision-making approach to the stochastic evaluation of heath care technologies
31. Selecting treatments: A decision theoretic approach
32. Updating uncertainty in an integrated risk assessment: Conceptual framework and methods
33. Risk-based environmental remediation: Bayesian Monte Carlo analysis and the expected value of sample information
34. Prevention of mother-to-child transmission of HIV-1 infection: Alternative strategies and their cost-effectiveness
35. Assessing the effectiveness of health interventions
36. Bayesian methods in health technology assessment
37. An estimate of the prevalence of human immunodeficiency virus in England and Wales by using a direct method
38. Direct estimates of prevalent HIV infection in adults in England and Wales for 1991 and 1993
39. Indirect methods for estimating prevalent HIV infections: Adults in England and Wales at the end of 1993
40. Publication and related biases